VALIDATING PERIPHERAL CC12 AND CCR2 AS NOVEL TARGETS FOR CHRONIC MIGRAINE THERAPEUTICS

$1,879,753FY2018Defense Health AgencyDOD

Washington University, The

Investigators

View source on USAspending →